News
New CEO at life sciences tech firm Chemaxon
Chemaxon, which supports software development for life science research, has announced the appointment of Richard Jones as CEO, taking over from business owner Ferenc Csizmadia.
Jones said: “Chemaxon has a great reputation globally. Following on from my work in Lab of the Future, I am excited about the opportunity to take data in science and technology and use it to do amazing things, together with our expert team and our expanding range of users.
“We have great plans for the coming years, and we will be reaching out to our customers shortly to share them.”
Chemaxon’s founder and outgoing CEO, Ferenc Csizmadia, steps down after almost seven years at the helm of the company he founded 24 years ago
He said: “We have worked closely with Richard to align strategy and culture, in order to ensure Chemaxon’s continued success. I have all confidence in his ability to take the company further, and look forward to seeing the company grow and flourish under his leadership.”
Csizmadia is moving on having founded Ancestralize, focusing on health and well-being in the digital age.
Microsoft invests £2.5 billion in UK AI
TMS shows promise in tackling depression ‘epidemic’
AI depression app set for NHS clinical trial
UK Biobank releases world’s largest single set of sequencing data
Listen: Longevity, Eastern wisdom and Western science
Fundamental principles of healthcare digital twins
Tackling the diagnostic testing sustainability problem
Gym-going men ‘unaware’ of protein risk to fertility
Anti-choke mug protects Parkinson’s patients
AI model predicts breast cancer risk without racial bias
Diagnostics3 weeks ago3D model will advance understanding of spinal injury pathology
- Opinion7 days ago
Why it’s time to revisit workplace mental health initiatives and make them work for everyone
- AI3 weeks ago
AI can help predict survival outcomes for cancer patients
- Research4 days ago
Tackling the diagnostic testing sustainability problem
